Gary Bridger
Chief Tech/Sci/R&D Officer at LIMINAL BIOSCIENCES INC.
Net worth: 71 817 $ as of 2024-03-30
Network origin in Gary Bridger first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 29 | |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
21
| Extinct | Pharmaceuticals: Major | 21 |
University of Manchester Institute of Science & Technology
21
| College/University | Other Consumer Services | 21 |
| Public Company | Biotechnology | 21 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
14
| Subsidiary | Medical Specialties | 14 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases.
13
| Extinct | Pharmaceuticals: Major | 13 |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
| Subsidiary | Pharmaceuticals: Major | 6 | |
Five Corners Capital, Inc.
 Five Corners Capital, Inc. Investment ManagersFinance Five Corners Capital Inc (Five Corners Capital) is a venture capital firm founded in 2013 by Kenneth Galbraith and Gary Bridger. The firm is headquartered in British Columbia, Canada.
1
| Private Company | Investment Managers | 1 |
Ventures West Management, Inc.
 Ventures West Management, Inc. Investment ManagersFinance Ventures West Management, Inc. is venture capital firm headquartered in Vancouver, British Columbia with additional offices in Toronto, Montréal and Kanata, Ontario
1
| Extinct | Investment Managers | 1 |
| Public Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gary Bridger via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELGENE | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Public Communications Contact | |
| SEAGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| YARA INTERNATIONAL ASA | Chemicals: Agricultural | Human Resources Officer Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| AFFYMAX, INC. | Biotechnology | Chief Operating Officer Director of Finance/CFO | |
Astrea Bioseparations Ltd.
 Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
| Concordia University | College/University | Undergraduate Degree Masters Business Admin | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Montréal | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Bishop's University | College/University | Undergraduate Degree Undergraduate Degree | |
| Loughborough University | College/University | Undergraduate Degree Masters Business Admin | |
Québec Bar Assoication
 Québec Bar Assoication Financial ConglomeratesFinance The Québec Bar Association is a professional organization that oversees the practice of over 29,000 lawyers in all areas of law. The organization is based in Montréal, Canada. and has subsidiaries in Canada. The mission of the association is to ensure the protection of the public, contribute to accessible and quality justice, and defend the rule of law. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member | |
BiVACOR, Inc.
 BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member Director/Board Member | |
Imanova Ltd.
 Imanova Ltd. BiotechnologyHealth Technology Imanova Ltd. provides research and development solutions in biomarkers. It offers clinical imaging, preclinical imaging, analysis and consultancy, access to academic expertise, and consumer health. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| PROFOUND MEDICAL CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
Thomvest Asset Management, Inc.
 Thomvest Asset Management, Inc. Financial ConglomeratesFinance Thomvest Asset Management, Inc. operates as an investment company. The private company is based in Redwood City, CA and it is not specified if it has any subsidiaries. | Financial Conglomerates | Chief Investment Officer President Director/Board Member | |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The private company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
ProMetic Plasma Resources, Inc.
 ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Part of Grifols SA, ProMetic Plasma Resources, Inc. operates plasma donation centers. The private company is based in Winnipeg, Canada. ProMetic Plasma Resources was acquired by Grifols Canada Therapeutics, Inc. from Kedrion SpA on January 04, 2022 for $3.13 million. | Medical/Nursing Services | Chief Executive Officer Chairman | |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Executive Officer Chief Operating Officer | |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member Director/Board Member | |
Fairhaven Pharmaceuticals, Inc.
 Fairhaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Fairhaven Pharmaceuticals, Inc. engages in the research and development of small molecule antagonists that target chemoattractant and activator of eosinophils, which play a key role in type 2 inflammation-driven diseases. The company was founded on May 4, 2018 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member President Investor Relations Contact |
Statistics
International
| United States | 30 |
| Canada | 15 |
| United Kingdom | 6 |
| Norway | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 478 |
| Corporate Officer/Principal | 231 |
| Independent Dir/Board Member | 134 |
| Chairman | 85 |
| Undergraduate Degree | 80 |
Most connected contacts
| Insiders | |
|---|---|
| Beth Seidenberg | 39 |
| Elaine Jones | 37 |
| Simon Geoffrey Best | 32 |
| Scott Rocklage | 32 |
| Michael Wyzga | 31 |
| Ken Galbraith | 30 |
| Peter Bisgaard | 28 |
| Dan Friedberg | 26 |
| Doug Onsi | 25 |
| David Jeans | 24 |
| Alison Lawton | 24 |
| Andrew Phillips | 23 |
| Paul Johnson | 21 |
| Bruce Wendel | 19 |
| Louise Ménard | 18 |
- Stock Market
- Insiders
- Gary Bridger
- Company connections
